We postulate that insulin resistance stimulates activation of the PGC‐1a/FNDC5 pathway as a compensatory response in effort to increase insulin sensitivity and attenuate impaired insulin signaling. The gene discussed is PPARGC1A; the disease is Insulin resistance.